Medroxyprogesterone contraindications

Contraindications
Genital bleeding Breast cancer Vascular disease Arterial thromboembolic disease Liver problems Impairment of fertility Hypersensitivity Pregnancy

Genital bleeding
Undiagnosed abnormal genital bleeding. Return to top

Breast cancer
Known, suspected, or history of cancer of the breast. Return to top

Estrogen-dependent neoplasia
Known or suspected estrogen-dependent neoplasia. Return to top

Vascular disease
Active deep vein thrombosis, pulmonary embolism or a history of these conditions. Return to top

Arterial thromboembolic disease
Active or recent (e.g., within past year) arterial thromboembolic disease (e.g., stroke, myocardial infarction). Return to top

Liver problems
Liver dysfunction or disease. Return to top

Hypersensitivity
Medroxyprogesterone therapy should not be used in patients with known hypersensitivity to their ingredients. Return to top

Pregnancy
Known or suspected pregnancy. There is no indication for Medroxyprogesterone in pregnancy. There appears to be little or no increased risk of birth defects in children born to women who have used estrogen and progestins from oral contraceptives inadvertently during pregnancy. Return to top